The Department of Urologic Surgery’s Clinical Trials Office has been actively involved in a number of national and university-based trials that allow our patients access to cutting-edge medications, techniques, and diagnostic modalities. Clinical trials are available for many different disease processes. Our experienced staff can quickly determine by phone whether or not you may qualify for a certain trial.
Listed below are several of the current trials that are open for enrollment. If you are interested in finding out whether or not you qualify for participation in one of these trials, please contact Brenda Hughes, RN, CCRC at (615) 343-0445 or email@example.com.
STRIVE: A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide vs. Bicalutamide in Men with Prostate Cancer who have Failed Primary Androgen Deprivation Therapy. MDV3100-09
Bladder Cancer and Related Protocols
A Randomized, Phase 2, Open-Label Study Evaluating DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma. Protocol No. N10-1
BOTOX® for the Treatment of Urinary Incontinence due to Neurogenic Detrusor Overactivity in Patients with Multiple Sclerosis. Protocol No. 191622-117
A Multi-centre, Double-blink, Randomised Trial Investigating the Efficacy and Safety of a Combination Therapy, Desmopressin and Tolterodine, for Treatment of Overactive Bladder with Nocturia in Women. Protocol No. 000085/DesmoCOMBO II
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence, Global Clinical Number 13-003
No protocols open now for this indication
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study Evaluating the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Oxybutynin Chloride Topical Gel for the Treatment of Detrusor Overactivity Associated with A Neurological Condition in Pediatric Subjects. Protocol No. OG09002